{"name":"Children's Oncology Group","slug":"children-s-oncology-group","ticker":"","exchange":"","domain":"childrensoncologygroup.org","description":"","hq":"Monrovia","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"Lactobacillus plantarum strain 299","genericName":"Lactobacillus plantarum strain 299","slug":"lactobacillus-plantarum-strain-299","indication":"Prevention or mitigation of chemotherapy-induced gastrointestinal toxicity in pediatric cancer patients","status":"phase_3"},{"name":"Lactobacillus plantarum strain 299v","genericName":"Lactobacillus plantarum strain 299v","slug":"lactobacillus-plantarum-strain-299v","indication":"Prevention or mitigation of chemotherapy-induced gastrointestinal toxicity in pediatric cancer patients","status":"phase_3"},{"name":"in vitro sensitivity-directed chemotherapy","genericName":"in vitro sensitivity-directed chemotherapy","slug":"in-vitro-sensitivity-directed-chemotherapy","indication":"Pediatric solid tumors, including sarcomas and neuroblastoma","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ATM Kinase Inhibitor AZD1390","genericName":"ATM Kinase Inhibitor AZD1390","slug":"atm-kinase-inhibitor-azd1390","indication":"Glioblastoma","status":"phase_1"},{"name":"cereport","genericName":"cereport","slug":"cereport","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ATM Kinase Inhibitor AZD1390","genericName":"ATM Kinase Inhibitor AZD1390","slug":"atm-kinase-inhibitor-azd1390","phase":"phase_1","mechanism":"ATM kinase inhibitor","indications":["Glioblastoma"],"catalyst":""},{"name":"Lactobacillus plantarum strain 299","genericName":"Lactobacillus plantarum strain 299","slug":"lactobacillus-plantarum-strain-299","phase":"phase_3","mechanism":"Lactobacillus plantarum strain 299 is a probiotic bacterium that modulates the gut microbiome and intestinal barrier function to support immune homeostasis.","indications":["Prevention or mitigation of chemotherapy-induced gastrointestinal toxicity in pediatric cancer patients","Support of immune recovery and reduction of infection risk in hematopoietic stem cell transplant recipients"],"catalyst":""},{"name":"Lactobacillus plantarum strain 299v","genericName":"Lactobacillus plantarum strain 299v","slug":"lactobacillus-plantarum-strain-299v","phase":"phase_3","mechanism":"Lactobacillus plantarum strain 299v is a probiotic bacterium that modulates the gut microbiome and enhances intestinal barrier function and immune tolerance.","indications":["Prevention or mitigation of chemotherapy-induced gastrointestinal toxicity in pediatric cancer patients","Support of immune recovery and reduction of infection risk in pediatric hematopoietic stem cell transplant recipients"],"catalyst":""},{"name":"cereport","genericName":"cereport","slug":"cereport","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"in vitro sensitivity-directed chemotherapy","genericName":"in vitro sensitivity-directed chemotherapy","slug":"in-vitro-sensitivity-directed-chemotherapy","phase":"phase_3","mechanism":"In vitro sensitivity-directed chemotherapy selects chemotherapeutic agents based on the sensitivity of tumor cells tested in a laboratory setting.","indications":["Pediatric solid tumors, including sarcomas and neuroblastoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOTFZIYl9SUWQ3RDUwekVtQV9QREJaTGdsMmRnSmg1aGNsLUg4UzJ3cEJ1WXRwZlRWWnNfVjZBR3U1Q3liX1U3QzVSaldQTDVfaHVuNlFKQndCdTFmVTYycFdUSlVRMndxQXlKLVNsTVN4MVBnSDRNNVF2RGpPMDBXYkxJRkR1bEc5NUxRZ2I5a09QYm1qbkFaY3VHM2pJQ0daSkRtOUdMSlBheGIwSGpadjhmM0JjUFFWekJHbDVqQQ?oc=5","date":"2026-04-07","type":"trial","source":"Stock Titan","summary":"Can a hearing-loss drug help more adults on cisplatin? Arizona study starts - Stock Titan","headline":"Can a hearing-loss drug help more adults on cisplatin? Arizona study starts","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-04-07","type":"trial","source":"Pulse 2.0","summary":"Fennec Pharmaceuticals: University Of Arizona Cancer Center Investigator-Sponsored Study Advances PEDMARK In AYA And Adult Cancer Patients - Pulse 2.0","headline":"Fennec Pharmaceuticals: University Of Arizona Cancer Center Investigator-Sponsored Study Advances PEDMARK In AYA And Adu","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-04-07","type":"trial","source":"The Manila Times","summary":"Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center - The Manila Times","headline":"Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxPeWlwUUwxbXVsTndOWWZJcE54MGNUNS10c3RFR3VKS2kzU1lHLTJVcnNLTjd1Q3FIVExRU1QwWTB1UU1vVlV3U3phSmkxc0lDS09DVkdMLWxjWTY4M0Y3YmxVdDJMcUJscGZuUW9MMmJINFNzU0wxbl9pQ1VUX1dEeUhhaFZvZmNQOG9sbjN6U3RqcDNIUmRfM282VVotakROLU1IMTZkeG9sMWltWExMVGZBd1ZlZGQ1ckxfNkJmRFVmblBKMFlvd0s0VzBtRktwS0JjX2pDaUExMFpMZjlqa2htd0E0bHFsWHUxN3QyM1E5UlphS2hTU29GZFk0VzdqUXVmY0xvUlRKdlB4OWc?oc=5","date":"2026-03-04","type":"deal","source":"globenewswire.com","summary":"Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute - globenewswire.com","headline":"Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQQTVtQTVUbnQyRXd3RVBRZXdEYlRlUnc0aUhQVlFhY0l1SWtPbkVlVTlqMVRxby1ZYjltVDNvMXJ6OVVLV3A2TjFnbEY1VzhXT2x0Z3N4bHRIN24wSDZsWl9ZY3NzU1J4eTFfYnFMcE9GMnlxWG96dzZTYlJlN081MUstVlVTZmxIdERhc2E4cw?oc=5","date":"2025-12-17","type":"pipeline","source":"TTUHSC: DAILY DOSE","summary":"TTUHSC Cancer Researcher Honored by National Academy of Inventors - TTUHSC: DAILY DOSE","headline":"TTUHSC Cancer Researcher Honored by National Academy of Inventors - TTUHSC: DAILY DOSE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNQzdxM1BFQ2RDaGZmaks3YkZtNC1rNklNdW40cGJUeEgyU0JuR1NSUEtiRGJWVjkxVUx4bkpIbWt5WFJONkRiemFDSFBSX0VkSTVXR3pXNl91bEhUUms1bEMyUFBmbmU3VmRnZ1JkVEhLZnd3VFprTkl5N0RNR3cyUzBScEdYbEVPTEE5VVcxYm5saXA2cmx2cmpuRERWTURZWHNFVFp6T3dkWnhyUXN2YWFmeVM1ZFdRdGNaUEIyVQ?oc=5","date":"2025-02-04","type":"pipeline","source":"Sanofi","summary":"Childhood Cancer R&D Program: Developing and Accelerating Novel Therapies for Children With Cancer - Sanofi","headline":"Childhood Cancer R&D Program: Developing and Accelerating Novel Therapies for Children With Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5tZ1Z0UFRURXBfVVlyV2dWRnlwNE00anB0U05nRmQxb25aSUpLN1dmNTFlcHFnbE9mQU5YbDBWX29jMEoyZWtyM0xIMklDUjBOTDVXTHAtMUg0Y3JqeWlR?oc=5","date":"2024-09-11","type":"trial","source":"Nature","summary":"Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children’s Oncology Group study - Nature","headline":"Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children’s Oncology Group study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNcW9rTjA4WHpMVHFFTmN6bjNrelNzb04taldHbHRRR0FfMUZQeEJKWmRhRUsyUE1sSEt0QmJBeGVSYTktUnZfMUtmS0tLLXN4Z3VBRWV3WGVXMmFDSHdkaDlGcjJJNVlXV3V3VFhOSVN3UlMxa0FmVnFlMDRLRFMzVnhmU0pqMGJodGdNNmxab3lDZTdidDBacHN3UXVaaWkxWXYyRHNtTjhCU0FYU0I4SHlnQThqN0t3WEw3UUtB?oc=5","date":"2023-09-26","type":"trial","source":"pharmacytimes.com","summary":"Pharmacists to Take the Reins of Leading Clinical Trials for Children’s Oncology Group - pharmacytimes.com","headline":"Pharmacists to Take the Reins of Leading Clinical Trials for Children’s Oncology Group","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5CVWNybkQ2WmNVSmgwMWR5ZFJTOWlWWkliUDF6aTFuT0t4NG5lb1RoVEFjTUN2NHNUS1RHMFFVS0JheW9zQWtGcF95VkVseGNUSWdOeGU5a2NRb2tqMEsxeHF6SU1zNFN2YUE?oc=5","date":"2023-07-17","type":"pipeline","source":"Wiley Online Library","summary":"Children's Oncology Group's 2023 blueprint for research: Pharmacy - Ostrenga - 2023 - Pediatric Blood & Cancer - Wiley Online Library","headline":"Children's Oncology Group's 2023 blueprint for research: Pharmacy - Ostrenga - 2023 - Pediatric Blood & Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOZTRWUkdzX3o3RmdTWmxhNnFFdVRvRDFUUlFHclJoWjdrNVdRbXFJSl9WbEUxZ2Nyc0xLOWQyY3dKRk9LWEFxUGRSWC1OTkx6LWRxMFo3cUdoU05ELUctM2lkaU1tSzNXR09KeGlVc0pCTFdZbFg2bmIxTlhoRE1WTWNxVlQ5M2ViRnFLOXg5b1F3NmNhcy01UW8yQ3JMQVM1YnhRUG1vRndxSTV5SXBRQTluVlRjeGwzd0p3emt2SE1Zb25NSHpoM1JQYkV3YkNVOW1wakdEVldRYUthbmo3aThkbw?oc=5","date":"2023-04-21","type":"pipeline","source":"Public Health Institute","summary":"PHI’s Children’s Cancer Program Plays Critical Role in Health Outcomes, Increased Access to Health Services for Youth - Public Health Institute","headline":"PHI’s Children’s Cancer Program Plays Critical Role in Health Outcomes, Increased Access to Health Services for Youth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPWEpoNGo4Q0JBb1BndTlqZEZOUjZNZmZ3aWpSeERBUjdsdU1uYk8wdHZTeG5CQnY4QmNsUnRZQ2xDdTM1R2IzejlSMWYwNG04NXB1Sm5kZDBjMTZpRUNmcGlSa20yMUhSemZHUGp2ay1YT0pkbDR3a2s2ZzdtSmU2UGdtUQ?oc=5","date":"2023-02-08","type":"pipeline","source":"abbvie.com","summary":"Little patients, big impact: Our approach to pediatric oncology - abbvie.com","headline":"Little patients, big impact: Our approach to pediatric oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQRW5sQnlIQU5wMENpYmpYOHNUTlVlRHE1eTJ5MmtscDdKX3ZTT1pGUjJFNU16VjhzSk9oTDlYaHpxcncxcUJXUVlxdEVzWmw4RW91cXpKcWk4cUNnc0FxQ05FQnQ1MEZHeFBDNlZhV2R6OXZtVGxBZVZsaDBfNG5hYlZ4dDd4Rng4d0lGUw?oc=5","date":"2021-02-04","type":"pipeline","source":"OncLive","summary":"Surge of New Drugs Fuels Optimism in Pediatric Oncology - OncLive","headline":"Surge of New Drugs Fuels Optimism in Pediatric Oncology","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_1":2,"phase_3":3},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}